NGI, YTI, dan Ndaru kolaborasi tingkatkan skrining dini thalassemia
NGI, YTI, and Ndaru collaborate to enhance early screening for thalassemia
Thalassemia is a genetic blood disorder that affects the production of hemoglobin, leading to anemia and other complications. It is estimated that around 7% of the Indonesian population carries the thalassemia gene, making it a significant public health concern in the country. Early detection and screening for thalassemia are crucial in order to provide timely intervention and management for affected individuals.
In an effort to improve early screening for thalassemia, three leading healthcare organizations in Indonesia, namely the National Genetics Institute (NGI), Yayasan Thalassemia Indonesia (YTI), and Ndaru Thalassemia Foundation, have come together to collaborate on a comprehensive screening program. This collaboration aims to increase access to screening services, raise awareness about thalassemia, and provide support to individuals and families affected by the disorder.
The partnership between NGI, YTI, and Ndaru brings together their expertise in genetics, thalassemia research, and patient care to create a holistic approach to thalassemia screening. Through this collaboration, they aim to streamline the screening process, making it more efficient and accessible to a larger number of people. This includes providing education and training to healthcare professionals, developing screening guidelines, and implementing community outreach programs to raise awareness about thalassemia.
One of the key initiatives of this collaboration is the establishment of mobile screening units that will travel to various communities across Indonesia to provide free screening services. These units will be staffed by trained healthcare professionals who will conduct blood tests and genetic counseling for individuals at risk of thalassemia. By bringing screening services directly to the community, the collaboration hopes to reach a wider audience and identify individuals with thalassemia at an earlier stage.
In addition to screening services, NGI, YTI, and Ndaru are also working together to provide support and resources to individuals and families affected by thalassemia. This includes counseling services, educational materials, and access to treatment options. By offering comprehensive care and support, the collaboration aims to improve the quality of life for individuals living with thalassemia and their families.
Overall, the collaboration between NGI, YTI, and Ndaru represents a significant step forward in the fight against thalassemia in Indonesia. By combining their expertise and resources, these organizations are working towards a shared goal of enhancing early screening, raising awareness, and providing support to individuals affected by thalassemia. Through their collaborative efforts, they hope to make a positive impact on the lives of those living with thalassemia and ultimately reduce the burden of this genetic disorder on the Indonesian population.